Results 151 to 160 of about 20,475 (213)

The <i>Shigella flexneri</i> effector IpaH1.4 facilitates RNF213 degradation and protects cytosolic bacteria against interferon-induced ubiquitylation. [PDF]

Elife
Saavedra-Sanchez L, Dickinson MS, Apte SS, Zhang Y, De Jong M, Skavicus S, Heaton NS, Alto NM, Coers J.   +8 more
europepmc   +1 more source

Emergence of Extensively Drug-Resistant Shigellosis - United States, 2011-2023.

MMWR Morb Mortal Wkly Rep
Logan N, Birhane MG, McDonald SL, Alarcón J, Amador S, Anand M, Bachmann LH, Bernard K, Black LS, Chen AN, Cooley LA, Fortes ED, Gerard M, Jervis RH, Kimura AC, Lamba K, Latash J, Li L, Pederson G, Kauffman CP, Reynolds JL, Santiago R, Siemetzki-Kapoor U, Smole SC, Tagg KA, Vostok J, Webb HE, Francois Watkins LK, XDR Shigella Working Group.   +28 more
europepmc   +1 more source

Anti-Shigella activity and killing kinetics of compounds from MMV Pathogen and COVID Boxes: Identifying leads against Shigellosis. [PDF]

Curr Res Pharmacol Drug Discov
Tchokouaha Yamthe LR, Kengne Mediesse F, Melogmo Dongmo YK, Matchuenkam Gayap SR, Dize D, Tsouh Fokou PV, Boyom FF.   +6 more
europepmc   +1 more source

Profiling Selectivity for the <i>Shigella</i> Virulence Factor OspF. [PDF]

Biochemistry
McCurtin NP, Gazaferi A, Novick ND, Kim K, Lesser CF, Scheck RA.   +5 more
europepmc   +1 more source

Genomic insights into Shigella species isolated from small ruminants and manure in the North West Province, South Africa. [PDF]

Appl Microbiol Biotechnol
Motlhaping T, Ramatla T, Thekisoe O, Khasapane NG, Lekota KE.   +4 more
europepmc   +1 more source

First-in-Human Evaluation of the Safety, Genetic Stability, and Immunogenicity of an Attenuated Shigella flexneri 2a Live Vector Expressing Enterotoxigenic Escherichia coli Antigens, Vaccine Strain CVD 1208S-122. [PDF]

J Infect Dis
Chen WH, Barry EM, Toapanta FR, Pasetti MF, Sztein MB, Permala-Booth J, Tennant SM, Ortiz JR, Thomas C, McGilvray M, Roane L, Datar R, Liang Y, Levine MM.   +13 more
europepmc   +1 more source

Gasdermins against intracellular bacterial pathogens. [PDF]

Nat Microbiol
Souza FW, Liu Y, Trujillo J, Miao EA.
europepmc   +1 more source

Enteric botulinum neurotoxins facilitate infection by <i>Salmonella</i> and <i>Shigella</i>. [PDF]

Sci Adv
Fabris F, Brun P, Megighian A, Bernabè G, Castagliuolo I, Drigo I, Bano L, Lista F, Bernardini ML, Johnson EA, Montecucco C, Rossetto O.   +11 more
europepmc   +1 more source

PGLYRP4 Enhances Shigella flexneri Virulence by Promoting virF Transcription via the CpxA/R Two-Component System. [PDF]

Microbiologyopen
Trirocco R, Prosseda G.
europepmc   +1 more source

The incidence and antimicrobial resistance of Shigella-attributable diarrhoea in young children in low-income and middle-income countries from the multicountry Enterics for Global Health (EFGH) Shigella Surveillance Study: a prospective, facility-based hybrid surveillance study.

Lancet Glob Health
Yousafzai MT, Cornick J, Penataro Yori P, Hossain MJ, Keita AM, Atlas HE, Khanam F, Omore R, Galagan SR, Ahmed N, Ahmmed F, Awuor AO, Badji H, Conteh B, Garcia Quesada M, Garcia-Bardales PF, Horne B, Hotwani A, Houpt ER, Islam MT, Jere KC, Juma J, Liu J, Mategula D, Ogwel B, Okonji C, Onwuchekwa UU, Paredes Olortegui M, Platts-Mills JA, Qureshi S, Rajib MNH, Rogawski McQuade ET, Schiaffino F, Secka O, Sow SO, Witte D, Kotloff KL, Cunliffe NA, Clemens JD, Tennant SM, Qamar FN, Kosek MN, Pavlinac PB, Tapia MD, Ochieng JB, EFGH Consortium.   +45 more
europepmc   +1 more source